Lindsay Hladnik

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

Geoffrey L. Uy, Michael P. Rettig, Ibraheem Motabi et al. · Blood · 2012 · 388 citations · Full text

Medicine, Oncology, Pharmacology +15

Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Bryan Alexander, Lindsay Hladnik, Kristan Augustin et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2010 · 61 citations · Full text

Medicine, Hematology, Infectious Diseases +17

Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G‐CSF

Mike Martin, Kristan Augustin, Geoffrey L. Uy et al. · American Journal of Hematology · 2009 · 50 citations · Full text

Medicine, Hematology, Oncology +14

Cladribine in the Treatment of Acute Myeloid Leukemia: A Single-Institution Experience

Mike Martin, John S. Welch, Kristan Augustin et al. · Clinical Lymphoma & Myeloma · 2009 · 34 citations

Medicine, Hematology, Oncology +9

Assessment of an Alternative Meropenem Dosing Strategy Compared with Imipenem‐Cilastatin or Traditional Meropenem Dosing After Cefepime Failure or Intolerance in Adults with Neutropenic Fever

Heather Arnold, Peggy S. McKinnon, Kristan Augustin et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2009 · 13 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17